CDX-011

 

Topic mentions per year

Topic mentions per year

2010-2016
01220102016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
PURPOSE To determine if BRAF and/or MEK inhibitor-induced GPNMB expression renders melanomas sensitive to CDX-011, an antibody… (More)
Is this relevant?
2016
2016
Case Presentation, Management, and Outcome The patient is a 62-year-old female with stage IV triple-negative invasive ductal… (More)
  • figure 1
Is this relevant?
2014
2014
BACKGROUND Glembatumumab vedotin is an antibody-auristatin conjugate that targets cells expressing the transmembrane glycoprotein… (More)
Is this relevant?
2013
2013
Biological therapies play an increasing role in cancer treatment, although the number of naked antibodies showing clinical… (More)
Is this relevant?
Review
2013
Review
2013
Molecularly targeted therapies are rapidly growing with respect to their clinical development and impact on cancer treatment due… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2013
Review
2013
Biological therapies play an increasing role in cancer treatment, although the number of naked antibodies showing clinical… (More)
Is this relevant?
Review
2012
Review
2012
INTRODUCTION Breast cancer (BC) is the most common malignancy in women in the USA. Despite the multi-modality treatments that are… (More)
  • figure 1
  • table 1
  • table 2
Is this relevant?
2011
2011
The World Antibody Drug Conjugate Summit Europe, organized by Biorbis/ Hanson Wade was held in Frankfurt, Germany on February 21… (More)
Is this relevant?
2010
2010
PURPOSE Although the murine orthologue of glycoprotein nonmetastatic B (GPNMB), Osteoactivin, promotes breast cancer metastasis… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Review
2010
Review
2010
Uveal melanoma is an aggressive disease without effective adjuvant therapy for metastases. Despite genomic differences between… (More)
Is this relevant?